- Target ID, screening, and Hit ID.
- IND-enabling and clinical stages.
- Antibiotics based on iterations of existing therapeutics e.g. β-lactams, and vaccines.
- Standalone technology or model development.
- Infections caused by mycobacteria (including TB), fungal and Gram-positive pathogens other than aureus.
Posted 03 / 08 / 23